Fig. 4From: A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathwayEffect of the Ru complex 2b on LLC tumor growth and metastasis in C57BL/6 mice. a Dose-dependent volume curve of LLC tumors. b Tumor weights in treated C57BL/6 mice. c Representative images of metastasis in the lung. d The number of metastases. e Body distribution of 2b (5.0 mg/kg), represented by the mean ± SD (ng) of ruthenium per g of organ, n = 6Back to article page